CAS ID: | 77431-55-1 |
Molecular Formula: | C17H37N3O6 |
Molecular Weight: | 379.5 g/mol |
Monoisotopic Mass: | 379.268 g/mol |
Class: | Peptide |
Natural Product: | No |
Other Names: | |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 28212548 | Target ID | |
Uniprot ID | Name | ||
Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
Process I | attenue inflammation | ||
Process II | HSCs-to-myofibroblasts | ||
Process III | prevenet collagen deposition | ||
Mechanism | Targeting NFY and p300 |
Trial Record 1
ClinicalTrial ID | NCT02837302 | Disease | Liver fibrosis |
Phase | Phase 4 | Status | Unknown |
First Received | July 19, 2016 | Last Verified | October 31, 2016 |
Sponsor | Kyungpook National University |
PubChem: | 9907842 |
ChEMBL: |